This does not make genchoice or GenSure obsolete. There is enough differention not just at the target audience level but at pricing as well. TodayKs news could have been in the Genprecis announcement from last week. However, I think there are developments on the partner level which led up to this. Re balance sheet and share count, I agree with you. It is premature to talk about exact numbers but 6% market share is by no means capturing the whole market or dominating the industry. It is a very reasonable assumption given the product features. More or less will depend on who they go ahead w. It should be a big name w significant distribution network.
(0)
(0)
Decision Diagnostics Corp (DECN) Stock Research Links